Broadwater Capital’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-278
Closed -$2.97K 217
2025
Q3
$2.97K Sell
278
-2,413
-90% -$23.7K ﹤0.01% 191
2025
Q2
$2.69M Buy
2,691
+2,413
+868% +$24.9K ﹤0.01% 196
2025
Q1
$4.14K Hold
278
﹤0.01% 181
2024
Q4
$4.15K Sell
278
-2,900
-91% -$47.3K ﹤0.01% 187
2024
Q3
$60.8K Hold
3,178
0.04% 112
2024
Q2
$65.8K Hold
3,178
0.05% 109
2024
Q1
$59.7K Sell
3,178
-720
-18% -$12.4K 0.05% 114
2023
Q4
$56.2K Buy
+3,898
New +$53K 0.04% 114

Other funds holding OGN

Broadwater Capital's OGN Position: Q4 2025 in Review

Broadwater Capital sold out of Organon & Co (OGN) in Q4 2025, closing a stake of 278 shares — an estimated $2.97K sold.

Broadwater Capital first reported a position in OGN in Q4 2023 and held it in 8 quarters. The position peaked at $2.69M in Q2 2025. 632 funds tracked by Wall St. Rank hold OGN as of Q4 2025.

  • Broadwater Capital reported no remaining Organon & Co position as of Q4 2025 after selling out during the quarter.
  • Broadwater Capital sold 278 Organon & Co shares in Q4 2025, an estimated $2.97K.
  • Broadwater Capital first reported a position in Organon & Co in Q4 2023 and held it in 8 quarters.
  • Broadwater Capital's Organon & Co position peaked at $2.69M in Q2 2025.
  • 632 funds tracked by Wall St. Rank held Organon & Co as of Q4 2025.

Based on Broadwater Capital's 13F filing for Q4 2025, filed 3 Feb 2026.